ANTIBIO

ANTIBIO

ANTIBIOtic therapy after an acute myocardial infarction. A clinical trial that asked whether treatment with a macrolide antibiotic, roxithromycin, would alter the outcomes of acute myocardial infarction. 
Conclusion Roxithromycin changed neither the 1-year mortality nor combined outcomes.